← ANALYST RATINGS · TIPRANKS
MBX Biosciences, Inc. (MBX): analyst forecast and price target
Price targets and ratings of
Analyst consensus
Strong Buy5 Buy0 Hold0 Sell
Ratings of 5 analysts in the last 3 months · top analysts only12-month forecast
$106+114.1% upside
Based on 5 price targets given in the last 3 months, the average target is $106, the highest $150, the lowest $84.00. The average is +114.1% from the last price of $49.61.
Highest target $150
Average target $106
Lowest target $84.00
Analyst ratings 15
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $54.00 → $53.00−1.9% | Hold | +6.8% | Reiterated | 17.10.26on TipRanks 15:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $53.00 → $52.00−1.9% | Hold | +4.8% | Downgrade | 17.10.26on TipRanks 15:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $53.00 → $52.00−1.9% | Hold | +4.8% | Reiterated | 17.10.26on TipRanks 15:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $53.00 → $52.00−1.9% | Hold | +4.8% | Reiterated | 17.10.26on TipRanks 15:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $52.00 → $51.00−1.9% | Hold | +2.8% | Reiterated | 17.10.26on TipRanks 15:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $51.00 → $53.00+3.9% | Hold | +6.8% | Reiterated | 16.10.26on TipRanks 20:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $52.00 → $54.00+3.8% | Hold | +8.8% | Reiterated | 16.10.26on TipRanks 10:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $51.00 → $53.00+3.9% | Hold | +6.8% | Downgrade | 16.10.26on TipRanks 10:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $51.00 → $53.00+3.9% | Hold | +6.8% | Reiterated | 16.10.26on TipRanks 10:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $52.00 → $53.00+1.9% | Hold | +6.8% | Reiterated | 16.10.26on TipRanks 10:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $50.00 → $52.00+4.0% | Hold | +4.8% | Reiterated | 16.10.26on TipRanks 10:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $55.00 → $52.00−5.5% | Hold | +4.8% | Reiterated | 15.10.26on TipRanks 03:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $55.00 → $51.00−7.3% | Hold | +2.8% | Downgrade | 15.10.26on TipRanks 03:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $55.00 → $51.00−7.3% | Hold | +2.8% | Reiterated | 15.10.26on TipRanks 03:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $55.00 → $52.00−5.5% | Hold | +4.8% | Reiterated | 15.10.26on TipRanks 03:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $53.00 → $50.00−5.7% | Hold | +0.8% | Reiterated | 15.10.26on TipRanks 03:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $56.00 → $51.00−8.9% | Hold | +2.8% | Reiterated | 14.10.26on TipRanks 08:07 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $56.00 → $55.00−1.8% | Hold | +10.9% | Reiterated | 14.10.26on TipRanks Oct 13 22:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $56.00 → $55.00−1.8% | Hold | +10.9% | Downgrade | 14.10.26on TipRanks Oct 13 22:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $56.00 → $55.00−1.8% | Hold | +10.9% | Reiterated | 14.10.26on TipRanks Oct 13 22:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $56.00 → $55.00−1.8% | Hold | +10.9% | Reiterated | 14.10.26on TipRanks Oct 13 22:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $54.00 → $53.00−1.9% | Hold | +6.8% | Reiterated | 14.10.26on TipRanks Oct 13 22:05 | — | |
| Eliana Merle★★★★★★★★★★#4163 · hits 45% · avg +3.0% | Barclays | $88.00 | Buy | +77.4% | Reiterated | 13.10.26on TipRanks 04:50 | −5.8%next day +0.7% | ↗ |
| Seamus Fernandez★★★★★★★★★★#129 · hits 66% · avg +30.6% | Guggenheim | $150 | Buy | +202.4% | Reiterated | 12.10.26on TipRanks 07:30 | −2.2%next day −5.8% | ↗ |
| Annabel Samimy★★★★★★★★★★#421 · hits 51% · avg +19.3% | Stifel Nicolaus | $70.00 → $84.00+20.0% | Buy | +69.3% | Reiterated | 12.10.26on TipRanks 07:20 | −2.2%next day −5.8% | ↗ |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $58.00 → $56.00−3.4% | Hold | +12.9% | Reiterated | 10.10.26on TipRanks 03:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $57.00 → $56.00−1.8% | Hold | +12.9% | Downgrade | 10.10.26on TipRanks 03:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $57.00 → $56.00−1.8% | Hold | +12.9% | Reiterated | 10.10.26on TipRanks 03:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $58.00 → $56.00−3.4% | Hold | +12.9% | Reiterated | 10.10.26on TipRanks 03:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $56.00 → $54.00−3.6% | Hold | +8.8% | Reiterated | 10.10.26on TipRanks 03:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $57.00 → $56.00−1.8% | Hold | +12.9% | Reiterated | 09.10.26on TipRanks 11:15 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $60.00 → $58.00−3.3% | Hold | +16.9% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $60.00 → $57.00−5.0% | Hold | +14.9% | Downgrade | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $60.00 → $57.00−5.0% | Hold | +14.9% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $60.00 → $58.00−3.3% | Hold | +16.9% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $58.00 → $56.00−3.4% | Hold | +12.9% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $59.00 → $57.00−3.4% | Hold | +14.9% | Reiterated | 08.10.26on TipRanks 05:07 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $62.00 → $60.00−3.2% | Hold | +20.9% | Reiterated | 08.10.26on TipRanks Oct 7 21:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $61.00 → $60.00−1.6% | Hold | +20.9% | Downgrade | 08.10.26on TipRanks Oct 7 21:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $61.00 → $60.00−1.6% | Hold | +20.9% | Reiterated | 08.10.26on TipRanks Oct 7 21:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $62.00 → $60.00−3.2% | Hold | +20.9% | Reiterated | 08.10.26on TipRanks Oct 7 21:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $60.00 → $58.00−3.3% | Hold | +16.9% | Reiterated | 08.10.26on TipRanks Oct 7 21:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $60.00 → $62.00+3.3% | Hold | +25.0% | Reiterated | 03.10.26on TipRanks 04:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $59.00 → $61.00+3.4% | Hold | +23.0% | Downgrade | 03.10.26on TipRanks 04:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $59.00 → $61.00+3.4% | Hold | +23.0% | Reiterated | 03.10.26on TipRanks 04:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $60.00 → $62.00+3.3% | Hold | +25.0% | Reiterated | 03.10.26on TipRanks 04:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $58.00 → $60.00+3.4% | Hold | +20.9% | Reiterated | 03.10.26on TipRanks 04:05 | — | |
| Seamus Fernandez★★★★★★★★★★#129 · hits 66% · avg +30.6% | Guggenheim | $88.00 → $150+70.5% | Buy | +202.4% | Assigned | 02.10.26on TipRanks 06:55 | +2.7%next day −0.6% · 5 days −10.2% | ↗ |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $62.00 → $60.00−3.2% | Hold | +20.9% | Reiterated | 02.10.26on TipRanks 03:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $62.00 → $59.00−4.8% | Hold | +18.9% | Downgrade | 02.10.26on TipRanks 03:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $56.00 → $59.00+5.4% | Hold | +18.9% | Reiterated | 02.10.26on TipRanks 03:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $62.00 → $59.00−4.8% | Hold | +18.9% | Reiterated | 02.10.26on TipRanks 03:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $62.00 → $60.00−3.2% | Hold | +20.9% | Reiterated | 02.10.26on TipRanks 03:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $60.00 → $58.00−3.3% | Hold | +16.9% | Reiterated | 02.10.26on TipRanks 03:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $61.00 → $62.00+1.6% | Hold | +25.0% | Reiterated | 01.10.26on TipRanks 02:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $60.00 → $62.00+3.3% | Hold | +25.0% | Downgrade | 01.10.26on TipRanks 02:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $60.00 → $62.00+3.3% | Hold | +25.0% | Reiterated | 01.10.26on TipRanks 02:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $61.00 → $62.00+1.6% | Hold | +25.0% | Reiterated | 01.10.26on TipRanks 02:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $59.00 → $60.00+1.7% | Hold | +20.9% | Reiterated | 01.10.26on TipRanks 02:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $61.00 | Hold | +23.0% | Reiterated | 30.09.26on TipRanks 01:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $60.00 | Hold | +20.9% | Downgrade | 30.09.26on TipRanks 01:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $60.00 | Hold | +20.9% | Reiterated | 30.09.26on TipRanks 01:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $61.00 | Hold | +23.0% | Reiterated | 30.09.26on TipRanks 01:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $59.00 | Hold | +18.9% | Reiterated | 30.09.26on TipRanks 01:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $56.00 | Hold | +12.9% | Reiterated | 28.09.26on TipRanks 00:05 | — | |
| Jessica Fye★★★★★★★★★★#1182 · hits 56% · avg +9.4% | J.P. Morgan | $88.00 | Buy | +77.4% | Initiated | 21.08.26on TipRanks 06:36 | −0.4%next day +0.4% · 5 days −5.5% | ↗ |
| Annabel Samimy★★★★★★★★★★#421 · hits 51% · avg +19.3% | Stifel Nicolaus | $70.00 | Buy | +41.1% | Reiterated | 11.08.26on TipRanks Aug 12 22:05 | +0.1%next day +1.2% · 5 days +1.2% | ↗ |
| Srikripa Devarakonda★★★★★★★★★★#200 · hits 62% · avg +26.3% | Truist Financial | $70.00 → $88.00+25.7% | Buy | +77.4% | Reiterated | 10.08.26on TipRanks 10:21 | −2.4%next day +0.1% · 5 days +3.2% | ↗ |
| Patrick Dolezal★★★★★★★★★★#1287 · hits 44% · avg +15.1% | LifeSci Capital | $121 | Buy | +143.9% | Assigned | 08.08.26on TipRanks Aug 6 12:50 | −0.4%next day +0.4% · 5 days −1.3% | ↗ |
| Eliana Merle★★★★★★★★★★#4163 · hits 45% · avg +3.0% | Barclays | $70.00 → $88.00+25.7% | Buy | +77.4% | Reiterated | 07.08.26on TipRanks 06:25 | +0.4%next day −2.4% · 5 days +0.7% | ↗ |
| Michael Yee★★★★★★★★★★#3077 · hits 49% · avg +3.8% | UBS | $60.00 → $90.00+50.0% | Buy | +81.4% | Reiterated | 24.07.26on TipRanks Jul 23 21:15 | −2.6%next day −1.2% · 5 days +5.2% | ↗ |
| Seamus Fernandez★★★★★★★★★★#129 · hits 66% · avg +30.6% | Guggenheim | $88.00 | Buy | +77.4% | Reiterated | 14.07.26on TipRanks 07:10 | −6.1%next day +6.8% · 5 days +7.0% | ↗ |
| Unknown Analyst | Oppenheimer | $80.00 | Buy | +61.3% | Reiterated | 15.06.26on TipRanks 08:15 | +8.0%next day +3.4% · 5 days +21.6% | ↗ |
| Jonathan Wolleben★★★★★★★★★★#249 · hits 53% · avg +23.6% | Citizens JMP | $76.00 → $86.00+13.2% | Buy | +73.4% | Reiterated | 12.05.26on TipRanks 05:50 | −7.6%next day +0.8% · 5 days −17.2% | ↗ |
| Tyler Van Buren★★★★★★★★★★#42 · hits 64% · avg +38.8% | TD Cowen | — | Buy | — | Reiterated | 07.05.26on TipRanks 16:25 | +17.2%next day −2.4% · 5 days −21.0% | ↗ |
| Corinne Johnson★★★★★★★★★★#1634 · hits 55% · avg +11.6% | Goldman Sachs | $31.97 | Sell | −35.6% | Initiated | 04.12.25on TipRanks Dec 5 02:40 | −10.1%next day +4.5% · 5 days −7.6% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering MBX Biosciences, Inc.
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
3 months
Srikripa Devarakonda★★★★★★★★★★Truist Financial · #200
Hits 62%225 of 360
Average return +26.3%
Most profitable
3 months
Srikripa Devarakonda★★★★★★★★★★Truist Financial · #200
Hits 62%225 of 360
Average return +26.3%
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $90.43 at a price of $58.62 (+54.3%); now: $101 at $49.61 (+104.2%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 16 | 18 | 11 | 4 | 4 |
| Buy | 4 | 3 | 3 | 6 | 5 | 4 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.83 (from $-1.05 to $-0.69). Last quarter: $-0.78.
Best top-analyst consensus in the sector · General
About MBX Biosciences, Inc.
- CEO: Steve Hoerter
- Employees: 63
- 11711 N. Meridian Street, Carmel, IN, 46032, US
- mbxbio.com
MBX Biosciences, Inc. is a biopharmaceutical company in its clinical development phase, dedicated to pioneering precise peptide-based therapies for endocrine and metabolic conditions. Its most advanced drug candidate, MBX 2109, is a parathyroid hormone peptide prodrug currently in Phase 2 clinical trials. This medication is being evaluated as a long-duration hormone replacement treatment for individuals suffering from chronic hypoparathyroidism. The company is also progressing with MBX 1416, a prolonged-action glucagon-like peptide-1 (GLP-1) receptor antagonist, which is undergoing Phase 1 clinical assessment. The aim of this therapy is to address post-bariatric hypoglycemia, a persistent complication often seen after weight-loss surgery. Furthermore, MBX Biosciences is developing MBX 4291, a key candidate for obesity treatment. This highly potent and long-acting prodrug functions as a co-agonist for both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. It is currently in investigational new drug (IND)-enabling studies, with the intention of treating obesity and its associated health issues. Founded in 2018, the company's operations are headquartered in Carmel, Indiana.
Data from the stock’s TipRanks forecast page, read 11 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗